IC
Ikarian Capital Portfolio holdings
AUM
$302M
This Quarter Return
+43.34%
1 Year Return
+65.21%
3 Year Return
+441.33%
5 Year Return
+548.26%
10 Year Return
–
AUM
$350M
AUM Growth
+$350M
(+8.8%)
Cap. Flow
+$11.3M
Cap. Flow
% of AUM
3.22%
Top 10 Holdings %
Top 10 Hldgs %
41.9%
Holding
166
New
42
Increased
21
Reduced
58
Closed
16
Top Buys
| 1 |
Scholar Rock
SRRK
|
$15.4M |
| 2 |
Forte Biosciences
FBRX
|
$13.8M |
| 3 |
TG Therapeutics
TGTX
|
$8.77M |
| 4 |
BPMC
Blueprint Medicines
BPMC
|
$7.36M |
| 5 |
Vir Biotechnology
VIR
|
$6.59M |
Top Sells
| 1 |
Tarsus Pharmaceuticals
TARS
|
$23.4M |
| 2 |
Soleno Therapeutics
SLNO
|
$11.2M |
| 3 |
TECX
Tectonic Therapeutic, Inc. Common Stock
TECX
|
$5.76M |
| 4 |
Arcus Biosciences
RCUS
|
$5.44M |
| 5 |
Capricor Therapeutics
CAPR
|
$4.56M |
Sector Composition
| 1 | Healthcare | 100% |
| 2 | Consumer Staples | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Amylyx Pharmaceuticals
AMLX
$877M
| $760K | 0.1% |
201,187
-73,364
| -27% | -$277K |
|
77
Kezar Life Sciences
KZR
$28.5M
| $718K | 0.1% |
106,901
+2
| +0% | +$13 |
|
78
Nurix Therapeutics
NRIX
$723M
| $659K | 0.09% |
34,985
-225,015
| -87% | -$4.24M |
|
79
BiomX
PHGE
$14.1M
| $652K | 0.09% |
892,976
-24
| -0% | -$18 |
|
80
Inhibrx
INBX
$403M
| $649K | 0.09% |
42,122
-1
| -0% | -$15 |
|
81
Aethlon Medical
AEMD
$3.51M
| $645K | 0.09% |
+93,750
| New | +$645K |
|
82
Veru
VERU
$48.5M
| $615K | 0.08% |
94,524
-114
| -0.1% | -$742 |
|
83
Corbus Pharmaceuticals
CRBP
$121M
| $607K | 0.08% |
51,431
-233,284
| -82% | -$2.75M |
|
|
ITOS
84
DELISTED
iTeos Therapeutics
ITOS
| $604K | 0.08% |
78,585
+11
| +0% | +$84 |
|
85
Sana Biotechnology
SANA
$759M
| $595K | 0.08% |
+365,000
| New | +$595K |
|
86
Olema Pharmaceuticals
OLMA
$432M
| $536K | 0.07% |
91,994
-6
| -0% | -$35 |
|
87
Acumen Pharmaceuticals
ABOS
$84.2M
| $457K | 0.06% |
265,769
-666
| -0.2% | -$1.15K |
|
88
MindMed
MNMD
$689M
| $436K | 0.06% |
62,691
+210
| +0.3% | +$1.46K |
|
|
SPRB
89
DELISTED
Spruce Biosciences, Inc. Common Stock
SPRB
| $420K | 0.06% |
+1,000,000
| New | +$420K |
|
90
Travere Therapeutics
TVTX
$1.75B
| $394K | 0.05% |
+22,600
| New | +$394K |
|
|
ELEV
91
DELISTED
Elevation Oncology
ELEV
| $388K | 0.05% |
690,050
-39
| -0% | -$22 |
|
|
CMMB
92
Chemomab Therapeutics
CMMB
$15.7M
| $386K | 0.05% |
53,263
-85
| -0.2% | -$615 |
|
93
Perspective Therapeutics
CATX
$251M
| $345K | 0.05% |
+108,300
| New | +$345K |
|
94
Sensei Biotherapeutics
SNSE
$10.9M
| $319K | 0.04% |
32,498
-2
| -0% | -$20 |
|
95
Voyager Therapeutics
VYGR
$204M
| $316K | 0.04% |
55,766
-91
| -0.2% | -$516 |
|
|
CLYM
96
Climb Bio, Inc. Common Stock
CLYM
$165M
| $315K | 0.04% |
175,088
-12
| -0% | -$22 |
|
|
ATXI
97
DELISTED
Avenue Therapeutics, Inc. Common Stock
ATXI
| $280K | 0.04% |
+140,000
| New | +$280K |
|
98
Karyopharm Therapeutics
KPTI
$61.4M
| $277K | 0.04% |
27,260
-30
| -0.1% | -$304 |
|
99
Anebulo Pharmaceuticals
ANEB
$101M
| $265K | 0.04% |
157,720
-142
| -0.1% | -$239 |
|
100
MacroGenics
MGNX
$121M
| $260K | 0.04% |
80,071
-8
| -0% | -$26 |
|